January 06, 2005 09:01 ET

GlaxoSmithKline Selects CambridgeSoft Electronic Notebook Software



JANUARY 6, 2005 - 09:01 ET

GlaxoSmithKline Selects CambridgeSoft Electronic
Notebook Software

CAMBRIDGE, Mass.--(CCNMatthews - Jan 6, 2005) -

CambridgeSoft Corporation, the leading provider of E-Notebook Solutions
has entered into an agreement with GlaxoSmithKline (GSK) to provide
software licensing to GSK's Global R&D facilities.

GSK selected CambridgeSoft's E-Notebook for the flexibility it
demonstrated across the wide range of data generated in the many
disciplines and functional areas within GSK's Discovery R&D
organization. GSK is partnering with CambridgeSoft to customize the
E-Notebook to meet GSK requirements and integrate with key applications
and workflow tools.

"CambridgeSoft is pleased to be selected by GSK as their global partner
for an E-Notebook for the Discovery R&D organization." said Michael G.
Tomasic, Chairman and CEO, CambridgeSoft Corporation. "We welcome GSK to
our growing list of top-tier pharmaceutical companies who are working
with CambridgeSoft in collaboratively designing and developing solutions
to meet their critical data management needs."

CambridgeSoft develops and markets life science enterprise solutions for
pharmaceutical, biotechnology, chemical companies and academic research
organizations. Software products include desktop, workgroup and
enterprise versions of Chem & Bio Office, including ChemDraw, with
knowledge management, chemical and biological informatics, and
scientific database solutions. Web sites include ChemFinder.Com and
ChemBioNews.Com for indexed database content and news, and SciStore.Com
for e-commerce. For information about CambridgeSoft products, services,
and resellers worldwide, please visit, or call 1
800 315-7300 or 1 617 588-9100.


Contact Information